Literature DB >> 7400759

Regulation of arachidonic acid metabolites in macrophages.

W A Scott, J M Zrike, A L Hamill, J Kempe, Z A Cohn.   

Abstract

The lipids of mouse peritoneal macrophages contain high levels (25 mole percent) of esterified arachidonic acid (20:4). Following in vitro exposure to unopsonized zymosan, these cells synthesize and release oxygenated products of 20:4. Maximal levels of zymosan ingestion promote the release of 40-50% of the 20:4 content of cultures without loss of viabilitiy. Release of radiolabel from macrophages prelabeled with [3H]20:4 provides a quantitative measure for the synthesis of 20:4-derived products. Approximately 67% of the released 20:4 is recovered as prostaglandins (PG) (51% PGE and 16% 6-oxo-PGF1 alpha) and the remainder as apolar products tentatively identified as hydroxy-eicosatetraenoic acids. The kinetics of synthesis are comparable for both sets of products. A detailed examination of PGE synthesis indicated the PGE levels rise in parallel with phagocytosis during a continuous exposure of macrophages to zymosan. The concentration of particles determines the initial rate of PGE release, but the time-course of synthesis is finite (approximately 60 min), regardless of the zymosan dose. These observations are compatible with the notion that phagocytosis results in a burst of PG synthesis, the size of which is determined by the phagocytic stimulus. This is supported by the finding that secondary challenges of zymosan promote new rounds of PG synthesis by macrophages.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400759      PMCID: PMC2185936          DOI: 10.1084/jem.152.2.324

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Biosynthesis of 9-alpha,15-dihydroxy-11-ketoprost-13-enoic acid.

Authors:  E Granström; W E Lands; B Samuelsson
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

Review 2.  Prostaglandins.

Authors:  B Samuelsson; E Granström; K Green; M Hamberg; S Hammarström
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

3.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

4.  Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles.

Authors:  R J Mason; T P Stossel; M Vaughan
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

5.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.

Authors:  P Borgeat; M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

6.  Dehydration of prostaglandins: study by spectroscopic method.

Authors:  N H Andersen
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

7.  Response of endocytosis to altered fatty acyl composition of macrophage phospholipids.

Authors:  E M Mahoney; A L Hamill; W A Scott; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Analyses of prostaglandins in human semen. Prostaglandins and related factors 44.

Authors:  M Bygdeman; B Samuelsson
Journal:  Clin Chim Acta       Date:  1966-04       Impact factor: 3.786

9.  Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.

Authors:  F M Griffin; C Bianco; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  71 in total

1.  Inhibition of alveolar macrophage spreading and phagocytosis by cotton bract tannin. A potential mechanism in the pathogenesis of byssinosis.

Authors:  T J Kreofsky; J A Russell; M S Rohrbach
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Composition of mouse peritoneal macrophage phospholipid molecular species.

Authors:  C C Akoh; R S Chapkin
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

3.  Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages.

Authors:  C C Leslie; D M Detty
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

4.  Immunoglobulin G-induced single ionic channels in human alveolar macrophage membranes.

Authors:  D J Nelson; E R Jacobs; J M Tang; J M Zeller; R C Bone
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

5.  Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Authors:  A Dulioust; E Vivier; N Meslier; R Roubin; I Haye-Legrand; J Benveniste
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

6.  Effects of Pasteurella haemolytica A1 culture supernatant on mechanisms controlling bovine alveolar macrophage oxygen radical production.

Authors:  P D Conlon; P E Shewen; S F Donnelly; J P Burger
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

7.  Depletion of glutathione selectively inhibits synthesis of leukotriene C by macrophages.

Authors:  C A Rouzer; W A Scott; O W Griffith; A L Hamill; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 8.  Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

Authors:  Laurence S Harbige
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

9.  The expression of functional IL-2 receptor on activated macrophages depends on the stimulus applied.

Authors:  S Valitutti; A Carbone; F Castellino; N Maggiano; R Ricci; L M Larocca; P Musiani
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

10.  Circulating cytotoxic immune components in dominant Charcot-Marie-Tooth syndrome.

Authors:  L L Williams; B T Shannon; F S Wright
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.